We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Radiologists Accurately Differentiate Between COVID-19 and Other Atypical Pneumonias on Chest CT, Finds Study

By MedImaging International staff writers
Posted on 21 Oct 2021
Print article
Illustration
Illustration

Radiologists can differentiate COVID-19 from other atypical pneumonias on chest computed tomography (CT) but performed worse in the early and late CT stage of COVID 19 pneumonia, according to the findings of a new study.

The study was conducted by researchers at Heidelberg University Hospital (Heidelberg, Germany) to examine the performance of radiologists in differentiating COVID-19 from non-COVID-19 atypical pneumonia and to perform an analysis of CT patterns in a study cohort including viral, fungal and atypical bacterial pathogens.

Nucleic acid tests, most commonly via reverse transcription polymerase chain reaction (RT-PCR) assay, represent the standardized test for the detection of SARS-CoV-2 RNA from respiratory clinical specimens with a specificity reaching 100%. Besides RT-PCR, chest CT has turned out to be a helpful and fast tool in diagnosing COVID-19 pneumonia, with a moderate to high overall sensitivity of 75-88%. However, compared to the highly specific RT-PCR, the specificity of chest CT in diagnosing COVID-19 is lower, with a reported overall specificity of 46-80%. This can be explained by the fact that typical signs of COVID-19 pneumonia partially overlap with that of other acute and chronic pulmonary conditions. Some of the findings frequently encountered in COVID-19 pneumonia are: ground glass opacities (GGO), consolidation, crazy paving and enlargement of sub-segmental vessels (diameter greater than 3 mm) in areas of GGO.

The aim of this study was to investigate the diagnostic performance of radiologists with different level of experience in differentiating COVID-19 pneumonia from other atypical bacterial, fungal and viral pneumonias. Furthermore, the ability of radiologists to correctly classify infiltrates as COVID-19 pneumonia was tested for every one of the described CT stages of the disease. In addition, the study performed a detailed analysis of infiltrate patterns of all pneumonias included, aiming at identifying those atypical pneumonias most similar to COVID-19 pneumonia and defining imaging markers that might help distinguish COVID-19 pneumonia from its top differential diagnoses. Patients with positive RT-PCR tests for COVID-19 pneumonia and non-COVID-19 atypical pneumonia were retrospectively included. Five radiologists, blinded to the pathogen test results, assessed the CT scans and classified them as COVID-19 or non-COVID-19 pneumonia. For both groups specific CT features were recorded and a multivariate logistic regression model was used to calculate their ability to predict COVID-19 pneumonia.

The radiologists differentiated between COVID-19 and non-COVID-19 pneumonia with an overall accuracy, sensitivity, and specificity of 88%, 79%, and 90%, respectively. The percentage of correct ratings was lower in the early and late stage of COVID-19 pneumonia compared to the progressive and peak stage (68% and 71% vs. 85% and 89%). The variables associated with the most increased risk of COVID-19 pneumonia were band like subpleural opacities, vascular enlargement, and subpleural curvilinear lines. Bronchial wall thickening and centrilobular nodules were associated with decreased risk of COVID-19 pneumonia with OR of 0.30 and 0.10, respectively.

The study concluded that radiologists can differentiate between COVID-19 and non-COVID-19 atypical pneumonias at chest CT with high overall accuracy, although a lower performance was observed in the early and late stage of COVID 19 pneumonia. Specific CT features might help to make the correct diagnosis. The diagnostic accuracy of radiologists in this study was higher compared to earlier studies which the researchers have attributed to the continuous growing experience of radiologists with the imaging findings of COVID-19 pneumonia since the detection of SARS-CoV-2 in December 2019. The study was the first to examine the radiologists’ performance in relation to the stage of the COVID-19 pneumonia and the first to search for the atypical pneumonias most often misdiagnosed as COVID-19.

Related Links:
Heidelberg University Hospital 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Portable X-Ray Unit
AJEX240H
New
PACS Workstation
CHILI Web Viewer
Compact C-Arm with FPD
Arcovis DRF-C R21

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.